Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

LinHealth

China drug medicine pharma prices

Cancer drugs “less affordable in low-income countries”

China and India are among those hit hardest by the rapidly escalating price of therapies

- PMLiVE

India denies Vertex patent on cystic fibrosis drug Orkambi

Says treatment is neither innovative or more effective than its predecessor

- PMLiVE

Indian court blocks generic of Merck’s Januvia

Follows a series of setbacks in Indian courts for multinational pharma companies

- PMLiVE

Anti-hypertensive market to slow in Asia-Pacific

New data shows the value will approach $20bn 2021

- PMLiVE

Former Langland exec joins DJM Unlimited

Michael Le Brocq becomes the firm’s new director

- PMLiVE

Think big, not small

In challenging times pharma will benefit from a collaborative approach

- PMLiVE

ICC Lowe head joins Cognite

Lee Hurley will be based in Zurich

Daiichi Sankyo logo

Daiichi Sankyo offloads stake in India’s Sun Pharma

Japanese firm wants to shed its share of the generic Indian drugmaker

- PMLiVE

India turns down patent on Gilead’s Sovaldi

Opens market to cheaper rivals for hepatitis C drug

- PMLiVE

Type 2 diabetes market in Asia-Pacific to hit $10.5bn by 2020

Analysts predict increase of $4bn from 2013 figure

- PMLiVE

First biosimilar Humira launches in India

AbbVie to face competition for world’s biggest-selling drug

Bristol-Myers Squibb (BMS) building

BMS to fund hepatitis projects in China and India

Pharma firm awards nine grants to support care for high-risk patients

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links